CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 33 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-09-14 | O'Neill Vincent Chief Medical Officer | Option exercise · Restricted Stock Units | −521 | 5,211 | ||
| 2023-09-14 | Mehta Vimal CEO and President | Option exercise | +2,610 | 29,613 | ||
| 2023-09-14 | Mehta Vimal CEO and President | Option exercise · Restricted Stock Units | −2,610 | 26,094 | ||
| 2023-06-26 | Bray June Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2023-06-26 | MUELLER PETER Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2023-06-26 | MILLER MICHAEL PATRICK Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2023-06-26 | Laumas Sandeep Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2023-06-26 | Votruba Michal Director | Grant or award · Stock Option (Right to Buy) | +17,000 | 17,000 | ||
| 2023-06-26 | Votruba Michal Director | Other disposition · Stock Option (Right to Buy) | −17,000 | 0 | ||
| 2023-06-16 | Mehta Vimal CEO and President | Option exercise 10b5-1 | +30,000 | $0.41 | $12K | 69,903 |
| 2023-06-16 | Mehta Vimal CEO and President | Sale 10b5-1 | −24,987 | $20.01 | $500K | 44,916 |
| 2023-06-16 | Mehta Vimal CEO and President | Sale 10b5-1 | −4,266 | $20.90 | $89K | 40,650 |
| 2023-06-16 | Mehta Vimal CEO and President | Sale 10b5-1 | −747 | $21.89 | $16K | 39,903 |
| 2023-06-16 | Mehta Vimal CEO and President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 294,000 | ||
| 2023-06-15 | Mehta Vimal CEO and President | Option exercise 10b5-1 | +30,000 | $0.41 | $12K | 69,903 |
| 2023-06-15 | Mehta Vimal CEO and President | Sale 10b5-1 | −21,988 | $21.41 | $471K | 47,915 |
| 2023-06-15 | Mehta Vimal CEO and President | Sale 10b5-1 | −8,012 | $21.90 | $175K | 39,903 |
| 2023-06-15 | Mehta Vimal CEO and President | Option exercise · Stock Option (Right to Buy) 10b5-1 | −30,000 | 324,000 | ||
| 2023-06-14 | Rodriguez Javier See Remarks | Option exercise | +521 | 4,871 | ||
| 2023-06-14 | Rodriguez Javier See Remarks | Option exercise · Restricted Stock Units | −521 | 5,732 |
Page 17 of 27 · 521 trades